Henry Meds vs MyStart Health

Choose Henry Meds if: You need tirzepatide access for superior weight loss efficacy (20.2% versus 13.7% average body weight loss in the SURMOUNT-5 head-to-head trial of the brand-name drugs; individual results vary), experienced suboptimal semaglutide response requiring alternative medications, prioritize platform maturity and operational stability for long-term treatment continuity, value an established track record (2+ years) and proven medication supply reliability - and note that on last-recorded figures (flat $149/month vs MyStart's $222/month, both last verified May 2026) Henry Meds is also the cheaper option.

Choose MyStart Health if: You respond adequately to semaglutide without needing tirzepatide, have verified current pricing directly (its last-recorded $222/month is higher than Henry Meds' last-recorded rate), and accept startup platform risks around supply consistency, don't require comprehensive medication formulary or treatment flexibility, or make purchasing decisions based primarily on lowest pricing.

Bottom line: Henry Meds and MyStart Health both provide budget-conscious compound semaglutide GLP-1 weight loss treatment with comparable basic consultation quality but differ in medication formulary and pricing. Henry Meds (last-recorded flat $149/month, last verified May 2026) offers broader medication access per its listing, an established 2+ year track record, and dependable supply. MyStart Health (last-recorded $222/month, semaglutide-only, last verified May 2026) is not the cheaper option on last-recorded figures and gives up tirzepatide access and platform maturity. For patients needing maximum efficacy or multi-year treatment reliability, Henry Meds justifies premium. Neither platform's listing is currently shown in our weight loss provider rankings, so verify pricing and availability directly before enrolling.